title: Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.
authors.affiliation: Institute of Pharmacy, Clinical Pharmacy, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Kanefendt
authors.forename: A
authors.initials: A
authors.lastname: Lindauer
authors.forename: M
authors.initials: M
authors.lastname: Kinzig
authors.forename: D
authors.initials: D
authors.lastname: Strumberg
authors.forename: M E
authors.initials: ME
authors.lastname: Scheulen
authors.forename: K
authors.initials: K
authors.lastname: Mross
authors.forename: R
authors.initials: R
authors.lastname: Fischer
authors.forename: B
authors.initials: B
authors.lastname: Moritz
authors.forename: F
authors.initials: F
authors.lastname: Sörgel
authors.forename: U
authors.initials: U
authors.lastname: Jaehde
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D042461:Vascular Endothelial Growth Factor A / Q000097:blood; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000032:analysis; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D007211:Indoles; D011758:Pyrroles; C544393:SU 12662; D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2; D040321:Vascular Endothelial Growth Factor Receptor-3; D000077210:Sunitinib